Prevalence of subclinical amyloidosis in Tunisian patients with rheumatoid arthritis
Younes M et al. - The prevalence of subclinical amyloidosis by AFAB is high (21.5%). AFAB is more sensitive than MSGB for detecting subclinical amyloidosis. A simple screening tool such as AFAB should be used, particularly in patients with risk factors. Subclinical amyloidosis requires close monitoring to ensure the early detection and treatment of symptomatic amyloidosis. [more...]
|
|
|
